Arrhythmias in patients receiving enzyme replacement therapy for infantile Pompe disease

QT dispersion: an indication of arrhythmia risk in patients with long QT intervals.

Christopher P. Day, Janet M. McComb, R. W. F. Campbell · Heart · 1990 · 1.2K citations · Full text

Medicine, Cardiology, Pharmacology +14

Magnitude of Left Ventricular Hypertrophy and Risk of Sudden Death in Hypertrophic Cardiomyopathy

Paolo Spirito, Pietro Bellone, Kevin M. Harris et al. · New England Journal of Medicine · 2000 · 1.1K citations · Full text

Medicine, Cardiology, Internal Medicine +14

Recombinant human acid α-glucosidase

Priya S. Kishnani, Deya Corzo, Marc Nicolino et al. · Neurology · 2006 · 772 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +10

Glycogen Storage Diseases Presenting as Hypertrophic Cardiomyopathy

Michael Arad, Barry J. Maron, Joshua Gorham et al. · New England Journal of Medicine · 2005 · 646 citations

Medicine, Cardiology, Pathology +14

A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease

Priya S. Kishnani, Wuh‐Liang Hwu, Hanna Mandel et al. · The Journal of Pediatrics · 2006 · 585 citations

Medicine, Neurology, Pediatrics +3